These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 21537013)

  • 1. Protein binding: do we ever learn?
    Zeitlinger MA; Derendorf H; Mouton JW; Cars O; Craig WA; Andes D; Theuretzbacher U
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3067-74. PubMed ID: 21537013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein binding of antimicrobials: methods for quantification and for investigation of its impact on bacterial killing.
    Beer J; Wagner CC; Zeitlinger M
    AAPS J; 2009 Mar; 11(1):1-12. PubMed ID: 19117135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro MIC break point for appropriate clinical use of antibiotic].
    Uete T; Matsuo K
    Jpn J Antibiot; 1993 Mar; 46(3):205-21. PubMed ID: 8510318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of erythrocytes on bacterial growth and antimicrobial activity of selected antibiotics.
    Nussbaumer-Pröll AK; Knotzer S; Eberl S; Reiter B; Stimpfl T; Jäger W; Poschner S; Zeitlinger M
    Eur J Clin Microbiol Infect Dis; 2019 Mar; 38(3):485-495. PubMed ID: 30687870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of glucose added urine on the in vitro antimicrobial activity of various antibiotics.
    Gönüllü N; Küçükbasmaci O; Büyükbaba-Boral O; Anğ-Küçüker M
    Indian J Med Res; 2008 Nov; 128(5):663-5. PubMed ID: 19179689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Simplified liquid nutrient media for controlling antibiotic activity, the spectrum of their antibacterial action and the sensitivity of microorganisms].
    Semenov SM; Tikhonov AS
    Antibiotiki; 1977 Mar; 22(3):216-9. PubMed ID: 15506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of protein binding of daptomycin on MIC and antibacterial activity.
    Lee BL; Sachdeva M; Chambers HF
    Antimicrob Agents Chemother; 1991 Dec; 35(12):2505-8. PubMed ID: 1667253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Susceptibility Testing Conditions on the In Vitro Antibacterial Activity of ETX0914.
    Giacobbe RA; Huband MD; deJonge BL; Bradford PA
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):139-142. PubMed ID: 27856046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
    Sarkar A; Anderson KC; Kellogg GE
    Eur J Med Chem; 2012 Jun; 52():98-110. PubMed ID: 22483632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical limitations of in vitro testing of microorganism susceptibility.
    Nightingale J
    Am J Hosp Pharm; 1987 Jan; 44(1):131-7. PubMed ID: 3826085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of plasma protein binding on antimicrobial activity using time-killing curves.
    Zeitlinger MA; Sauermann R; Traunmüller F; Georgopoulos A; Müller M; Joukhadar C
    J Antimicrob Chemother; 2004 Nov; 54(5):876-80. PubMed ID: 15472003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on penem antibiotics. II. In vitro activity of SUN5555, a new oral penem.
    Nishino T; Maeda Y; Ohtsu E; Koizuka S; Nishihara T; Adachi H; Okamoto K; Ishiguro M
    J Antibiot (Tokyo); 1989 Jun; 42(6):977-88. PubMed ID: 2661512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do we really know about antibiotic pharmacodynamics?
    Gunderson BW; Ross GH; Ibrahim KH; Rotschafer JC
    Pharmacotherapy; 2001 Nov; 21(11 Pt 2):302S-318S. PubMed ID: 11714222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antimicrobial activity of GSQ1530, a new heteroaromatic polycyclic compound.
    Ge Y; Difuntorum S; Touami S; Critchley I; Bürli R; Jiang V; Drazan K; Moser H
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3168-74. PubMed ID: 12234840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of in vitro activity and pharmacokinetic parameters with effect in vivo for antibiotics. Observations from experimental pneumococcus infection.
    Frimodt-Møller N
    Dan Med Bull; 1988 Oct; 35(5):422-37. PubMed ID: 3066588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents.
    Hyatt JM; McKinnon PS; Zimmer GS; Schentag JJ
    Clin Pharmacokinet; 1995 Feb; 28(2):143-60. PubMed ID: 7736689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hydrogen ion and protein concentrations on the activity of beta-lactam antibiotics.
    Platt R; Rosner B
    Rev Infect Dis; 1984; 6 Suppl 4():S829-34. PubMed ID: 6522925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro antibiotic inactivation by mammalian cell and killed bacterial preparations.
    Hunt GH; Oberholzer VG; Price EH
    J Antimicrob Chemother; 1987 May; 19(5):637-46. PubMed ID: 2440844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapy and pharmacodynamics in the management of bacterial infection.
    Rotschafer JC; Zabinski RA; Walker KJ; Vance-Bryan K
    J Clin Pharmacol; 1992 Dec; 32(12):1083-8. PubMed ID: 1487545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients.
    Ulldemolins M; Roberts JA; Rello J; Paterson DL; Lipman J
    Clin Pharmacokinet; 2011 Feb; 50(2):99-110. PubMed ID: 21142293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.